MAXCYTE, INC.·4

Mar 21, 4:43 PM ET

Masoud Maher 4

4 · MAXCYTE, INC. · Filed Mar 21, 2023

Insider Transaction Report

Form 4
Period: 2023-03-20
Masoud Maher
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-03-20+120,000120,000 total
    Exercise: $4.19Exp: 2033-03-19Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION